Submit Manuscript  

Article Details


Pure Biologics – From a Bootstrapped Boutique CRO to an Integrated Drug Discovery Public Company

[ Vol. 7 , Issue. 1 ]

Author(s):

Sameer Deshmukh, Przemysław Jurek, Filip Jelen, Sabina Tabaczar, Tomasz Bakowski, David Carter, Richard Fox, Marta Wawrzyniak and Maciej P. Mazurek*   Pages 48 - 63 ( 16 )

Abstract:


The present article is a case study of a Polish biopharmaceutical company, “Pure Biologics”. The company was founded in 2010 by a group of scientists and, over the last nine years, grew substantially from just a few individuals to nearly one hundred professionals. Initially, a privately-funded civil partnership, Pure Biologics, has been transformed into a publicly-traded company. Such a transformation has been possible not only because of the expertise and growing experience of corporate management, but also the specific economic environment and substantial public funding dedicated to innovative Small and Medium Enterprises (SMEs).

Keywords:

Small and Medium Enterprises (SMEs), immuno-oncology, Polish biopharmaceutical companies, therapeutic medical devices, aptamers, bispecific antibodies.

Affiliation:

Pure Biologics S.A. [Plc], Dunska 11, 54-427 Wroclaw, Pure Biologics S.A. [Plc], Dunska 11, 54-427 Wroclaw, Pure Biologics S.A. [Plc], Dunska 11, 54-427 Wroclaw, Pure Biologics S.A. [Plc], Dunska 11, 54-427 Wroclaw, Pure Biologics S.A. [Plc], Dunska 11, 54-427 Wroclaw, Pure Biologics S.A. [Plc], Dunska 11, 54-427 Wroclaw, Pure Biologics S.A. [Plc], Dunska 11, 54-427 Wroclaw, Pure Biologics S.A. [Plc], Dunska 11, 54-427 Wroclaw, Pure Biologics S.A. [Plc], Dunska 11, 54-427 Wroclaw



Read Full-Text article